Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Cutia Therapeutics

Market Cap 1B 1.16B 148M 129M 119M 112M 210M 13.98B 211M 1.42B 551M 6.89B 557M 545M 23.88B P/E 2026 *
-6.02x
P/E 2027 * 21.2x
Enterprise Value 1.07B 1.24B 159M 138M 127M 120M 224M 14.94B 226M 1.51B 588M 7.36B 595M 582M 25.52B EV / Sales 2026 *
1.66x
EV / Sales 2027 * 0.85x
Free-Float
33.73%
Yield 2026 *
-
Yield 2027 * -
1 day+3.90%
1 week-1.23%
Current month-10.86%
1 month-26.94%
3 months-36.00%
6 months-38.46%
Current year-29.52%
1 week 2.91
Extreme 2.91
3.41
1 month 2.91
Extreme 2.91
4.2
Current year 2.91
Extreme 2.91
5.51
1 year 2.91
Extreme 2.91
12
3 years 2.91
Extreme 2.91
32.5
5 years 2.91
Extreme 2.91
32.6
10 years 2.91
Extreme 2.91
32.6
Manager TitleAgeSince
Chief Executive Officer 48 01/09/2019
Director of Finance/CFO 36 10/05/2021
Chief Tech/Sci/R&D Officer 42 10/01/2020
Director TitleAgeSince
Chairman 63 23/08/2019
Director/Board Member 48 12/06/2023
Director/Board Member 57 30/12/2025
Date Insider Type Main position Quantity % Market Cap.
15/10/24Other

Founder

15,000 0.0049%
03/10/24Other

Chief Financial Officer

20,000 0.0066%
02/10/24Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
+3.90%-1.23%-69.58%-89.64% 143M
-1.13%-5.35%+39.97%+143.12% 992B
-2.46%-4.23%+51.43%+39.07% 564B
-2.24%-3.66%+16.75%+57.13% 391B
-2.90%+0.68%+24.66%+16.53% 330B
-2.36%-3.12%+24.71%+12.95% 280B
-2.45%-2.88%+24.29%+29.93% 279B
-1.91%-0.87%-41.95%-48.26% 196B
-1.65%-5.02%+16.11%+47.11% 184B
-1.95%-2.30%+13.86%+58.24% 156B
Average -1.60%-0.12%+10.02%+26.62% 337.14B
Weighted average by Cap. -2.05%-0.49%+27.85%+62.88%

Financials

2026 *2027 *
Net sales 646M 749M 95.54M 83.25M 76.74M 72.18M 135M 9B 136M 913M 355M 4.44B 359M 351M 15.38B 1.18B 1.37B 175M 152M 140M 132M 247M 16.45B 248M 1.67B 648M 8.11B 655M 641M 28.1B
Net income -146M -169M -21.56M -18.78M -17.31M -16.29M -30.47M -2.03B -30.68M -206M -80M -1B -80.92M -79.18M -3.47B 44.25M 51.3M 6.55M 5.7M 5.26M 4.95M 9.25M 617M 9.32M 62.55M 24.29M 304M 24.57M 24.04M 1.05B
Net Debt 68.7M 79.65M 10.16M 8.85M 8.16M 7.68M 14.36M 958M 14.46M 97.11M 37.71M 472M 38.14M 37.33M 1.64B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
304
Date Price Change Volume
18/06/26 3.200 $ +3.90% 8,800
17/06/26 3.080 $ +0.65% 98,604
16/06/26 3.060 $ -4.38% 31,800
15/06/26 3.200 $ -0.62% 99,600
12/06/26 3.220 $ -4.45% 174,400
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.760CNY
Average target price
9.801CNY
Spread / Average Target
+255.10%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!